228 related articles for article (PubMed ID: 866558)
1. Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines.
Krugman RD; Witte JJ; Parkman PD; Herrmann KL; Meyer HM; Wende RD; Meyer BC; Dungca R
Public Health Rep; 1977; 92(3):220-2. PubMed ID: 866558
[No Abstract] [Full Text] [Related]
2. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
3. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
Weibel RE; Buynak EB; Stokes J; Hilleman MR
Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
[No Abstract] [Full Text] [Related]
4. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
5. Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine.
Minekawa Y; Ueda S; Yamanishi K; Ogino T; Takahashi M
Biken J; 1974 Dec; 17(4):161-7. PubMed ID: 4464833
[TBL] [Abstract][Full Text] [Related]
6. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
Just M; Berger R; Glück R; Wegmann A
Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT
Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
[TBL] [Abstract][Full Text] [Related]
9. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
[TBL] [Abstract][Full Text] [Related]
10. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
Heath TC; Burgess MA; O'Brien ED
Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
[No Abstract] [Full Text] [Related]
11. Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine.
Topal B; Kanra G; Ceyhan M
Turk J Pediatr; 1991; 33(1):13-8. PubMed ID: 1844171
[TBL] [Abstract][Full Text] [Related]
12. Combined live measles, mumps, and rubella virus vaccines.
Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
[No Abstract] [Full Text] [Related]
13. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
[TBL] [Abstract][Full Text] [Related]
14. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
Weibel RE; Buynak EB; McLean AA; Hilleman MR
Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
[TBL] [Abstract][Full Text] [Related]
15. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination.
Lerman SJ; Bollinger M; Brunken JM
Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582
[TBL] [Abstract][Full Text] [Related]
17. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
18. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
Smorodintsev AA; Nasibov MN; Jakovleva NV
Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
[TBL] [Abstract][Full Text] [Related]
19. A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile.
Borgoño JM; Greiber R; Solari G; Concha F; Carrillo B; Hilleman MR
Clin Pediatr (Phila); 1973 Mar; 12(3):170-2. PubMed ID: 4701464
[No Abstract] [Full Text] [Related]
20. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
